NRNP 6645 (ADVANCED
PSYCHOPHARMACOLOGY) MIDTERM EXAM
PRACTICE — ACTUAL STUDY GUIDE, FULL
TESTBANK, 150 PRACTICE QUESTIONS & 100%
CORRECT ANSWERS WITH RATIONALES —
2026/2027 LATEST UPDATE
100+ QUESTIONS AND CORRECT ANSWERS
VERIFIED SOLUTIONS
FULL TESTBANK WITH RATIONALES
TABLE OF CONTENTS
i. Pharmacokinetics and pharmacodynamics
ii. Antidepressant pharmacotherapy
iii. Antipsychotic medications
iv. Mood stabilizers and bipolar disorder
v. Anxiolytics and sedative-hypnotic medications
vi. ADHD pharmacotherapy
vii. Substance use and medication-assisted treatment
viii. Drug interactions and adverse-effect management
ix. Special populations and individualized prescribing
x. Monitoring, safety, adherence, and clinical decision-making
xi. Evidence-based prescribing and professional considerations
,DESCRIPTION
This comprehensive NRNP 6645 Advanced Psychopharmacology practice
examination is designed for graduate-level psychiatric mental health nursing
students preparing for demanding midterm assessments. It evaluates applied
knowledge of pharmacokinetics, pharmacodynamics, antidepressants,
antipsychotics, mood stabilizers, anxiolytics, stimulants, substance-use
pharmacotherapy, adverse effects, drug interactions, monitoring, and
individualized medication management. The questions emphasize clinical
reasoning, medication selection, safety assessment, interpretation of patient
presentations, and management of complex adverse reactions rather than
simple memorization. It contains 100+ challenging questions and answers with
concise rationales to reinforce understanding and clinical judgment. Purchase
and instantly get a downloadable and editable PDF for convenient study,
review, and examination preparation.
QUESTIONS 1–150
Question 1
A patient begins an antidepressant that inhibits serotonin and norepinephrine reuptake. After
several weeks, the patient reports improved energy but persistent anhedonia. Which
pharmacologic principle best explains why increasing the dose may not necessarily produce
proportional clinical improvement?
A. Receptor occupancy and dose-response relationships are not always linear
B. Renal clearance always decreases as antidepressant doses increase
C. All antidepressants exhibit complete receptor saturation at therapeutic doses
D. Antidepressant efficacy is independent of pharmacodynamic effects
🔴 Correct Answer: A. Receptor occupancy and dose-response relationships are not
always linear.
🔵 Explanation: Pharmacodynamic dose-response relationships may demonstrate
plateaus, partial agonism, receptor adaptation, and nonlinear clinical effects. Increasing a
dose can increase adverse effects without producing a proportional increase in therapeutic
benefit.
Question 2
A patient with major depressive disorder has taken an SSRI consistently for 8 weeks at a
therapeutic dose with minimal improvement. Before immediately switching medications,
which assessment is most important?
A. Determine whether the patient has taken the medication only with meals
B. Confirm adherence, diagnosis, dose adequacy, duration, and contributing factors
C. Assume pharmacologic resistance and prescribe two antidepressants
D. Discontinue treatment without tapering
,🔴 Correct Answer: B. Confirm adherence, diagnosis, dose adequacy, duration, and
contributing factors.
🔵 Explanation: Apparent treatment resistance should first be differentiated from
inadequate adherence, insufficient duration or dosing, incorrect diagnosis, substance use,
medical contributors, or psychosocial factors.
Question 3
A patient taking an SSRI develops agitation, diaphoresis, diarrhea, tremor, hyperreflexia, and
clonus shortly after another serotonergic medication is added. What is the priority
interpretation?
A. Neuroleptic malignant syndrome
B. Serotonin syndrome
C. Anticholinergic toxicity
D. Lithium toxicity
🔴 Correct Answer: B. Serotonin syndrome.
🔵 Explanation: Acute autonomic instability, gastrointestinal symptoms, neuromuscular
hyperactivity, hyperreflexia, and clonus after serotonergic exposure strongly suggest
serotonin toxicity. Prompt discontinuation of serotonergic agents and supportive
management are priorities.
Question 4
A patient taking an SSRI reports mild nausea during the first week but remains clinically
stable. What is the most appropriate interpretation?
A. The medication must be permanently discontinued
B. Nausea necessarily indicates serotonin syndrome
C. Mild transient gastrointestinal effects can occur during initiation
D. The patient has developed hepatic failure
🔴 Correct Answer: C. Mild transient gastrointestinal effects can occur during
initiation.
🔵 Explanation: Gastrointestinal adverse effects are common early with serotonergic
antidepressants and may diminish with continued treatment. Severity, associated
symptoms, and clinical trajectory determine whether intervention is necessary.
Question 5
A patient abruptly stops a short-half-life antidepressant after long-term use and develops
dizziness, irritability, insomnia, and electric-shock sensations. Which phenomenon is most
likely?
A. Discontinuation syndrome
B. Hypertensive emergency
C. Tardive dyskinesia
D. Neuroleptic malignant syndrome
, 🔴 Correct Answer: A. Discontinuation syndrome.
🔵 Explanation: Abrupt cessation of some antidepressants, particularly those with shorter
half-lives, can cause neurologic, gastrointestinal, sleep, and affective symptoms. Gradual
tapering can reduce this risk.
Question 6
A patient taking an antidepressant develops markedly increased energy, decreased need for
sleep, grandiosity, pressured speech, and impulsive spending. What diagnostic concern
should be prioritized?
A. Persistent depressive disorder
B. Bipolar-spectrum illness
C. Panic disorder
D. Somatic symptom disorder
🔴 Correct Answer: B. Bipolar-spectrum illness.
🔵 Explanation: New-onset manic or hypomanic symptoms warrant reassessment for
bipolar disorder. Antidepressant exposure may complicate the presentation but should not
substitute for diagnostic evaluation.
Question 7
A patient with depression and chronic neuropathic pain is being considered for antidepressant
therapy. Which pharmacologic strategy may address both symptom domains?
A. Select a medication with serotonergic and noradrenergic activity
B. Select an exclusively sedating antihistamine
C. Use an anticholinergic medication as primary therapy
D. Select a dopamine antagonist exclusively
🔴 Correct Answer: A. Select a medication with serotonergic and noradrenergic
activity.
🔵 Explanation: Certain SNRIs have evidence for both depressive disorders and selected
chronic pain syndromes. Treatment should still be individualized based on comorbidities,
contraindications, and adverse-effect risks.
Question 8
A patient taking an antidepressant develops sexual dysfunction but has substantial
improvement in depressive symptoms. Which approach best reflects advanced medication
management?
A. Automatically discontinue the antidepressant
B. Assess severity, timing, relationship to treatment, and potential management strategies
C. Tell the patient the adverse effect is unrelated to medication
D. Increase the antidepressant dose
PSYCHOPHARMACOLOGY) MIDTERM EXAM
PRACTICE — ACTUAL STUDY GUIDE, FULL
TESTBANK, 150 PRACTICE QUESTIONS & 100%
CORRECT ANSWERS WITH RATIONALES —
2026/2027 LATEST UPDATE
100+ QUESTIONS AND CORRECT ANSWERS
VERIFIED SOLUTIONS
FULL TESTBANK WITH RATIONALES
TABLE OF CONTENTS
i. Pharmacokinetics and pharmacodynamics
ii. Antidepressant pharmacotherapy
iii. Antipsychotic medications
iv. Mood stabilizers and bipolar disorder
v. Anxiolytics and sedative-hypnotic medications
vi. ADHD pharmacotherapy
vii. Substance use and medication-assisted treatment
viii. Drug interactions and adverse-effect management
ix. Special populations and individualized prescribing
x. Monitoring, safety, adherence, and clinical decision-making
xi. Evidence-based prescribing and professional considerations
,DESCRIPTION
This comprehensive NRNP 6645 Advanced Psychopharmacology practice
examination is designed for graduate-level psychiatric mental health nursing
students preparing for demanding midterm assessments. It evaluates applied
knowledge of pharmacokinetics, pharmacodynamics, antidepressants,
antipsychotics, mood stabilizers, anxiolytics, stimulants, substance-use
pharmacotherapy, adverse effects, drug interactions, monitoring, and
individualized medication management. The questions emphasize clinical
reasoning, medication selection, safety assessment, interpretation of patient
presentations, and management of complex adverse reactions rather than
simple memorization. It contains 100+ challenging questions and answers with
concise rationales to reinforce understanding and clinical judgment. Purchase
and instantly get a downloadable and editable PDF for convenient study,
review, and examination preparation.
QUESTIONS 1–150
Question 1
A patient begins an antidepressant that inhibits serotonin and norepinephrine reuptake. After
several weeks, the patient reports improved energy but persistent anhedonia. Which
pharmacologic principle best explains why increasing the dose may not necessarily produce
proportional clinical improvement?
A. Receptor occupancy and dose-response relationships are not always linear
B. Renal clearance always decreases as antidepressant doses increase
C. All antidepressants exhibit complete receptor saturation at therapeutic doses
D. Antidepressant efficacy is independent of pharmacodynamic effects
🔴 Correct Answer: A. Receptor occupancy and dose-response relationships are not
always linear.
🔵 Explanation: Pharmacodynamic dose-response relationships may demonstrate
plateaus, partial agonism, receptor adaptation, and nonlinear clinical effects. Increasing a
dose can increase adverse effects without producing a proportional increase in therapeutic
benefit.
Question 2
A patient with major depressive disorder has taken an SSRI consistently for 8 weeks at a
therapeutic dose with minimal improvement. Before immediately switching medications,
which assessment is most important?
A. Determine whether the patient has taken the medication only with meals
B. Confirm adherence, diagnosis, dose adequacy, duration, and contributing factors
C. Assume pharmacologic resistance and prescribe two antidepressants
D. Discontinue treatment without tapering
,🔴 Correct Answer: B. Confirm adherence, diagnosis, dose adequacy, duration, and
contributing factors.
🔵 Explanation: Apparent treatment resistance should first be differentiated from
inadequate adherence, insufficient duration or dosing, incorrect diagnosis, substance use,
medical contributors, or psychosocial factors.
Question 3
A patient taking an SSRI develops agitation, diaphoresis, diarrhea, tremor, hyperreflexia, and
clonus shortly after another serotonergic medication is added. What is the priority
interpretation?
A. Neuroleptic malignant syndrome
B. Serotonin syndrome
C. Anticholinergic toxicity
D. Lithium toxicity
🔴 Correct Answer: B. Serotonin syndrome.
🔵 Explanation: Acute autonomic instability, gastrointestinal symptoms, neuromuscular
hyperactivity, hyperreflexia, and clonus after serotonergic exposure strongly suggest
serotonin toxicity. Prompt discontinuation of serotonergic agents and supportive
management are priorities.
Question 4
A patient taking an SSRI reports mild nausea during the first week but remains clinically
stable. What is the most appropriate interpretation?
A. The medication must be permanently discontinued
B. Nausea necessarily indicates serotonin syndrome
C. Mild transient gastrointestinal effects can occur during initiation
D. The patient has developed hepatic failure
🔴 Correct Answer: C. Mild transient gastrointestinal effects can occur during
initiation.
🔵 Explanation: Gastrointestinal adverse effects are common early with serotonergic
antidepressants and may diminish with continued treatment. Severity, associated
symptoms, and clinical trajectory determine whether intervention is necessary.
Question 5
A patient abruptly stops a short-half-life antidepressant after long-term use and develops
dizziness, irritability, insomnia, and electric-shock sensations. Which phenomenon is most
likely?
A. Discontinuation syndrome
B. Hypertensive emergency
C. Tardive dyskinesia
D. Neuroleptic malignant syndrome
, 🔴 Correct Answer: A. Discontinuation syndrome.
🔵 Explanation: Abrupt cessation of some antidepressants, particularly those with shorter
half-lives, can cause neurologic, gastrointestinal, sleep, and affective symptoms. Gradual
tapering can reduce this risk.
Question 6
A patient taking an antidepressant develops markedly increased energy, decreased need for
sleep, grandiosity, pressured speech, and impulsive spending. What diagnostic concern
should be prioritized?
A. Persistent depressive disorder
B. Bipolar-spectrum illness
C. Panic disorder
D. Somatic symptom disorder
🔴 Correct Answer: B. Bipolar-spectrum illness.
🔵 Explanation: New-onset manic or hypomanic symptoms warrant reassessment for
bipolar disorder. Antidepressant exposure may complicate the presentation but should not
substitute for diagnostic evaluation.
Question 7
A patient with depression and chronic neuropathic pain is being considered for antidepressant
therapy. Which pharmacologic strategy may address both symptom domains?
A. Select a medication with serotonergic and noradrenergic activity
B. Select an exclusively sedating antihistamine
C. Use an anticholinergic medication as primary therapy
D. Select a dopamine antagonist exclusively
🔴 Correct Answer: A. Select a medication with serotonergic and noradrenergic
activity.
🔵 Explanation: Certain SNRIs have evidence for both depressive disorders and selected
chronic pain syndromes. Treatment should still be individualized based on comorbidities,
contraindications, and adverse-effect risks.
Question 8
A patient taking an antidepressant develops sexual dysfunction but has substantial
improvement in depressive symptoms. Which approach best reflects advanced medication
management?
A. Automatically discontinue the antidepressant
B. Assess severity, timing, relationship to treatment, and potential management strategies
C. Tell the patient the adverse effect is unrelated to medication
D. Increase the antidepressant dose
